Scinai Expects Operating Runway Through Late 2027

Bitget2026/10/20 12:50

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Scinai Immunotherapeutics expects operating runway through late 2027, supported by recent financing and expected customer payments.
Activation and delivery of later CDMO project phases could extend runway into the third quarter of 2028, subject to sales, collections and execution.
Recent equity financing generated approximately $5.3 million in combined net proceeds, excluding future exercises of newly issued warrants.
A CDMO agreement includes approximately $5.1 million in committed base service fees, expected to contribute revenue during 2026 and 2027.
Additional uncommitted clinical manufacturing carries indicative service fees of approximately $5.85 million for late 2027 and the first half of 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scinai Immunotherapeutics Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610200849PR_NEWS_USPR_____IO76504) on October 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Scinai Expects Operating Runway Through Late 2027

You may also like

Crypto prices